Delivery Order SPE2DB22D3401-SPE2DB25FT6GM
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,827.12 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract. The delivery order was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, and represents a non-competitive, competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,703.72 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). This competitive award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,282.20 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). The contract, awarded on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a firm fixed-price procurement with no set-aside designation, indicating the award was competitively available. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $19,111.33 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This contract, executed on July 29, 2025, with an ultimate completion date of July 30, 2025, utilizes firm fixed-price pricing and was competitively awarded without any set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $51,982.18 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by September 18, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the point of performance for this pharmaceutical supply delivery. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $15,801.10 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) under a firm fixed-price contract type. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance for this...
- The Defense Logistics Agency awarded a delivery order valued at $16,421.59 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) under a firm fixed-price contract type. The order was competitively awarded without set-aside designation and is scheduled for completion by August 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery from its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,431.30 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). This contract, awarded on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $20,214.27 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on August 13, 2025, with completion expected by August 14, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation, leveraging the vendor's established relationship with DLA for pharmaceutical distribution. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $17,149.40 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages) with an ultimate completion date of August 26, 2025. This firm fixed price delivery order, awarded on August 25, 2025, represents a non-competitive set-aside award executed through open competition. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT6GMDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $70,217.89 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order was issued on September 17, 2025, with an ultimate completion date of September 18, 2025, and represents a direct pharmaceutical supply transaction with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor vehicle valued at $999,999,999.00 through December 2026. The parent IDC enables AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains a robust portfolio of competitively awarded contracts with the DLA for diverse therapeutic medications and medical commodities supporting defense and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $70.2k | 9/17/25 |